Verition Fund Management LLC Inovio Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.35 - $0.53 $52,500 - $79,500
-150,000 Reduced 49.99%
150,045 $76,000
Q3 2023

Nov 14, 2023
BUY
$0.38 - $0.58 $28,517 - $43,526
75,045 Added 33.35%
300,045 $117,000
Q2 2023

Aug 14, 2023
BUY
$0.39 - $0.94 $87,750 - $211,500
225,000 New
225,000 $101,000
Q2 2021

Aug 16, 2021
SELL
$6.23 - $10.03 $62,673 - $100,901
-10,060 Closed
0 $0
Q1 2021

May 18, 2021
BUY
$8.81 - $16.96 $88,628 - $170,617
10,060 New
10,060 $93,000

Others Institutions Holding INO

# of Institutions
10
Shares Held
281K
Call Options Held
0
Put Options Held
0
View Full List

About INOVIO PHARMACEUTICALS, INC.

INO Quotes by TradingView
  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $456M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email